Items where Author is "Oberneder, R."

Group by: Item Type | No Grouping

Number of items: 5.

Article

Reichle, A. and Vogelhuber, M. and Feyerabend, S. and Suedhoff, T. and Schulze, M. and Huebner, J. and Oberneder, R. and Ruebel, A. and Birkholz, K. and Bakhshandeh-Bath, A. and Andreesen, R. (2012) Combined anti-osteoplastic, anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC): Biologic features during therapy interruption and tumor progression. ONKOLOGIE, 35 (suppl6). p. 181. ISSN 0378-584X

Reichle, A. and Vogelhuber, M. and Feyerabend, S. and Suedhoff, T. and Schulze, M. and Huebner, J. and Oberneder, R. and Baier, M. and Ruebel, A. and Birkholz, K. and Bakhshandeh-Bath, A. and Andreesen, R. (2011) A phase II study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and low-dose Treosulfan: Final results of a combined anti-inflammatory, immunomodulatory and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC). ONKOLOGIE, 34 (Suppl6). p. 10. ISSN 0378-584X

Reichle, A. and Vogelhuber, M. and Feyerabend, S. and Suedhoff, T. and Schulze, M. and Hubner, J. and Oberneder, R. and Baier, M. and Ruebel, A. and Birkholz, K. and Bakhshandeh-Bath, A. and Andreesen, R. (2011) A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC). JOURNAL OF CLINICAL ONCOLOGY, 29 (15supp): 4599. ISSN 0732-183X, 1527-7755

Albrecht, M. and Vogelhuber, M. and Stenzl, A. and Feyerabend, S. and Walter, B. and Schulze, M. and Oberneder, R. and Rohrmann, K. and Schmidt, K. and Reichle, A. R. (2008) Anti-inflammatory and angiostatic therapy in hormone refractory prostate cancer (HRPC). EUROPEAN UROLOGY SUPPLEMENTS, 7 (3). p. 233. ISSN 1569-9056

This list was generated on Sat Mar 14 22:15:56 2026 CET.

Export as	Atom RSS 1.0 RSS 2.0